A Patient-Centric Platform Trial for Precision Oncology

Status unconfirmed

Conditions studied: Oncology

In brief

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Key facts

Study ID

NCT03793088

Run by

xCures

People needed

10000

Starts

2019-02-07

Expected to finish

2026-01-01

Last updated by the study team

2023-02-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
• Patients with any performance status, comorbidity or disease severity are eligible
• Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)

You may not qualify if…

• Patients must be a resident of or receiving care within the United States or US territories.

Where it is running

• Cancer Commons — Los Altos, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.